ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.43
1.25%
Dow Jones
38,675.30
1.18%
US Dollar vs MXN
16.9698
-0.01%
Brent Oil
82.82
-0.97%
Bitcoin
61,882.91
4.67%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Phathom Pharmaceuticals Inc (PHAT)

  7. Phathom Pharmaceuticals Inc (PHAT) Noticias

PHAT Phathom Pharmaceuticals Inc

9.87
0.11 (1.13%)
Última actualización: 14:40:50
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Phathom Pharmaceuticals Inc PHAT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.11 1.13% 9.87 14:40:50
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
10.35 9.84 10.37 9.76
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202407:00GLOBEPhathom Pharmaceuticals to Report First Quarter 2024..
03/4/202407:00GLOBEPhathom Pharmaceuticals to Participate in the 23rd Annual..
26/3/202407:00GLOBEPhathom Pharmaceuticals Launches Direct-to-Consumer..
07/3/202415:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202407:06EDGAR2Form 8-K - Current report
07/3/202407:00GLOBEPhathom Pharmaceuticals Reports Fourth Quarter and Full Year..
29/2/202407:00GLOBEPhathom Pharmaceuticals to Report Fourth Quarter and Full..
13/2/202407:05EDGAR2Form 8-K - Current report
13/2/202407:00GLOBEPhathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan)..
31/1/202407:00GLOBEPhathom Pharmaceuticals to Present at the Guggenheim..
22/1/202419:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202315:05EDGAR2Form 8-K - Current report
14/12/202307:05EDGAR2Form 8-K - Current report
14/12/202307:00GLOBEPhathom Pharmaceuticals Announces Expansion of Existing Loan..
06/12/202307:05EDGAR2Form 8-K - Current report
06/12/202307:00GLOBEPhathom Pharmaceuticals Announces FDA Acceptance for Filing..
28/11/202307:06EDGAR2Form 8-K - Current report
28/11/202307:00GLOBEPhathom Pharmaceuticals Announces Commercial Availability of..
19/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
09/11/202315:02EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202307:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202307:05EDGAR2Form 8-K - Current report
09/11/202307:00GLOBEPhathom Pharmaceuticals Reports Third Quarter 2023 Results..
08/11/202318:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202315:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202316:50DJNPhathom Pharmaceuticals Gets FDA Approval for Voquezna..
01/11/202316:06EDGAR2Form 8-K - Current report
01/11/202316:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of VOQUEZNA®..
30/10/202307:05EDGAR2Form 8-K - Current report
30/10/202307:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of..
25/10/202307:01GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
26/9/202307:05EDGAR2Form 8-K - Current report
26/9/202307:01GLOBEPhathom Pharmaceuticals Announces Vonoprazan NDA Submission..
05/9/202307:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
21/8/202307:07EDGAR2Form 8-K - Current report
21/8/202307:00GLOBEPhathom Pharmaceuticals Announces Submission of Six-Month..
10/8/202315:02EDGAR2Form 8-K - Current report
10/8/202307:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202307:01GLOBEPhathom Pharmaceuticals Reports Second Quarter 2023 Results
17/7/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202315:04EDGAR2Form 8-K - Current report
17/7/202315:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
12/6/202308:04DJNFDA Accepts Phathom Pharmaceuticals' Resubmission for..
12/6/202307:01GLOBEPhathom Pharmaceuticals Announces FDA Acceptance of NDA..
09/6/202315:01GLOBEPhathom Pharmaceuticals Announces Closing of Underwriters’..
09/6/202304:45PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
07/6/202304:45PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
02/6/202304:45PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
01/6/202307:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
30/5/202304:00PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..

Su Consulta Reciente

NASDAQ
PHAT
Phathom Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados